Pyxis Oncology builds a differentiated portfolio of biologics, including antibody-drug conjugates and immunotherapies, to improve the lives of patients with difficult-to-treat cancers.
For more details on financing and valuation for Pyxis Oncology, register or login.
Already registered? Click here to log in
To read this article and more news on Pyxis Oncology, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.